13-101407725-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_052867.4(NALCN):​c.-39-8560G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.641 in 152,074 control chromosomes in the GnomAD database, including 33,039 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.64 ( 33039 hom., cov: 32)

Consequence

NALCN
NM_052867.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.00100

Publications

5 publications found
Variant links:
Genes affected
NALCN (HGNC:19082): (sodium leak channel, non-selective) This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
NALCN Gene-Disease associations (from GenCC):
  • congenital contractures of the limbs and face, hypotonia, and developmental delay
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • hypotonia, infantile, with psychomotor retardation and characteristic facies 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • digitotalar dysmorphism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Freeman-Sheldon syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Sheldon-hall syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypotonia, infantile, with psychomotor retardation and characteristic facies
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • temporal lobe epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.853 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NALCNNM_052867.4 linkc.-39-8560G>A intron_variant Intron 1 of 43 ENST00000251127.11 NP_443099.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NALCNENST00000251127.11 linkc.-39-8560G>A intron_variant Intron 1 of 43 1 NM_052867.4 ENSP00000251127.6

Frequencies

GnomAD3 genomes
AF:
0.641
AC:
97365
AN:
151954
Hom.:
32981
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.861
Gnomad AMI
AF:
0.674
Gnomad AMR
AF:
0.669
Gnomad ASJ
AF:
0.523
Gnomad EAS
AF:
0.822
Gnomad SAS
AF:
0.591
Gnomad FIN
AF:
0.491
Gnomad MID
AF:
0.554
Gnomad NFE
AF:
0.520
Gnomad OTH
AF:
0.617
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.641
AC:
97482
AN:
152074
Hom.:
33039
Cov.:
32
AF XY:
0.640
AC XY:
47533
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.861
AC:
35733
AN:
41504
American (AMR)
AF:
0.669
AC:
10233
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.523
AC:
1815
AN:
3468
East Asian (EAS)
AF:
0.822
AC:
4245
AN:
5162
South Asian (SAS)
AF:
0.590
AC:
2841
AN:
4814
European-Finnish (FIN)
AF:
0.491
AC:
5186
AN:
10560
Middle Eastern (MID)
AF:
0.548
AC:
161
AN:
294
European-Non Finnish (NFE)
AF:
0.520
AC:
35349
AN:
67960
Other (OTH)
AF:
0.618
AC:
1306
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1632
3263
4895
6526
8158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
764
1528
2292
3056
3820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.577
Hom.:
9768
Bravo
AF:
0.667
Asia WGS
AF:
0.691
AC:
2406
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
2.5
DANN
Benign
0.48
PhyloP100
-0.0010
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1572591; hg19: chr13-102060076; API